Upgrades include end-of-life equipment replacements and relocation.
Worldwide Clinical Trials has announced an expansion of the pharmacy at its Clinical Pharmacology Unit (CPU) in San Antonio, Texas, according to a company press release.1 In addition to equipment upgrades, expansion efforts focused on operational demand, workplace demand, and employee engagement with the overall goal of enhancing customer experience. Completed in January 2024, the expanded pharmacy provides customers with streamlined processes, as well as decreased timelines and costs.
“A common thread among our Worldwide team members is a passion to take care of our customers—we’re always looking for ways to improve our partnerships,” said Mike Mencer, executive vice president and general manager, early phase, Worldwide Clinical Trials in the press release. “As part of an ongoing $5 million upgrade to our CPU, this expansion aligns with our culture of quality and our dedication to continuous improvement and innovation to meet our customers’ growing needs as we work together to improve the lives of patients around the world.”
Worldwide’s CPU, a 200-bed, fit-for-purpose facility, has been in operation since 2005. Within the unit, studies are conducted in healthy volunteers, patients, and specialty populations. The CPU is conveniently located one hour from Worldwide’s Bioanalytical Center of Excellence, offering an approach that benefits customers through streamlined vendor management, consistent standards, technical expertise, and overall efficiencies such as sample transfer and rapid processing.
“Expanding our pharmacy in size enables us to expand in volume, providing additional opportunities and efficiencies for our customers,” said Lona Sheeran, senior vice president, clinical operations, early phase, Worldwide Clinical Trials in the press release. “We can now manufacture onsite, in real time, for Phase I studies per FDA guidance, allowing our customers the option to pivot on their dose while their study is ongoing. This service is unique and can save our customers thousands of dollars and months of time—a huge advantage in this fast-paced industry.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.